Ten Dam Leroy, van der Kooi Anneke J, Rövekamp Fleur, Linssen Wim H J P, de Visser Marianne
Department of Neurology, Academic Medical Centre, Amsterdam, The Netherlands.
Department of Neurology, Academic Medical Centre, Amsterdam, The Netherlands.
Neuromuscul Disord. 2014 Dec;24(12):1097-102. doi: 10.1016/j.nmd.2014.07.004. Epub 2014 Aug 1.
In this retrospective cross-sectional study clinical and muscle imaging data of patients with Miyoshi distal myopathy phenotype (MMD1 and MMD3) and limb girdle muscular dystrophy 2L (LGMD2L) were described. MMD1 and MMD3 are genetically heterogenous diseases based on DYSF and ANO5 gene defects. MMD3 and LGMD2L are clinically different diseases caused by an ANO5 gene defect. All groups showed predominant fatty degeneration of the gluteus minimus muscle and of the posterior segments of the thigh and calf muscles with sparing of the gracilis muscle. Muscle atrophy, hypertrophy and asymmetric muscle involvement on muscle imaging did not differ between groups. The pattern of fatty degeneration of muscles and of muscle weakness shows only minor differences between MMD1 (n=6) and MMD3 (n=8) patients with more frequently fatty degeneration of the rectus femoris, anterior tibial, and extensor digitorum muscles and more frequently muscle weakness in the anterior tibial, peroneal and calf muscle in MMD1. In the ANO5 related phenotypes the lateral head of the gastrocnemius muscle was less frequently involved in LGMD2L (n=13) and no differences in the incidence of muscle weakness was found. Therefore, MMD3 and LGMD2L should be considered as part of one spectrum of ANO5 related muscle disease.
在这项回顾性横断面研究中,描述了宫下远端肌病表型(MMD1和MMD3)以及肢带型肌营养不良2L(LGMD2L)患者的临床和肌肉影像学数据。MMD1和MMD3是基于DYSF和ANO5基因缺陷的遗传异质性疾病。MMD3和LGMD2L是由ANO5基因缺陷引起的临床不同疾病。所有组均显示臀小肌以及大腿和小腿肌肉后段出现明显的脂肪变性,而股薄肌未受累。各组之间在肌肉影像学上的肌肉萎缩、肥大和不对称肌肉受累情况并无差异。MMD1(n = 6)和MMD3(n = 8)患者之间,肌肉脂肪变性模式和肌无力情况仅存在细微差异,MMD1患者中股直肌、胫骨前肌和趾长伸肌更常出现脂肪变性,胫骨前肌、腓骨肌和小腿肌肉更常出现肌无力。在与ANO5相关的表型中,LGMD2L(n = 13)患者腓肠肌外侧头较少受累,且未发现肌无力发生率存在差异。因此,MMD3和LGMD2L应被视为与ANO5相关的肌肉疾病谱的一部分。